SCHEMBL7651639

SCHEMBL7651639

O=C(O)C(c1ccccc1)N(c1ccccn1)[PH](=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
POLB P06746 2/20 0.36
PTPRA P18433 1/20 0.36
HTT P42858 2/20 0.35
GAA P10253 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP1A2 P05177 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
LMNA P02545 2/20 0.35
NAPRT Q6XQN6 1/20 0.35
P4HTM Q9NXG6 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 1/20 0.35
OPRK1 P41145 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7655136 0.78 CYP2D6 (0.39) TSHRHTTGAAALDH1A1CYP1A2
SCHEMBL7644687 0.75 HDAC1 (0.38) TSHRPOLBPTPRAALDH1A1HSD17B10
SCHEMBL7650927 0.74 TSHR (0.41) TSHRHTTGAAALDH1A1KMT2A
SCHEMBL28679009 0.68 POLB (0.44) TSHRPOLBPTPRAGAAALDH1A1
SCHEMBL4461877 0.66 SLC6A2 (0.48) TSHRPOLBHTTALDH1A1CYP1A2
SCHEMBL15348824 0.65 TSHR (0.50) TSHRPOLBHTTALDH1A1CYP1A2
SCHEMBL4953717 0.65 POLB (0.44) TSHRPOLBPTPRAGAAALDH1A1
SCHEMBL4953723 0.65 POLB (0.44) TSHRPOLBPTPRAGAAALDH1A1
SCHEMBL935444 0.64 HTT (0.54) TSHRPOLBHTTALDH1A1NPC1
SCHEMBL7904906 0.64 KMT2A (0.54) TSHRPOLBHTTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed